Publications
Search our publications, laboratory reports, meeting statements, scheduling submissions and scheduling decisions.
Can't find what you’re looking for? You can also:
- search our Resources
- use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- (-) Committees and advisory bodies (384)
- Scheduling (national classification system) (166)
- Safety monitoring and information (27)
- Advertising (25)
- COVID-19 (11)
- Manufacturing (11)
- Clinical trials (6)
- Medicinal cannabis hub (6)
- Sunscreens (5)
- Compliance and enforcement (4)
- Fees and payments (4)
- Shortages and supply disruptions (4)
- Legislation (3)
- Import and export (2)
- Breast implant hub (1)
- Cosmetics (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Prescription opioids hub (1)
- Unique Device Identification (UDI) hub (1)
Search
386 result(s) found, displaying 276 to 300
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in November 2018
-
Scheduling decisions (final)Final decisions and reasons for NCEs and medicines and chemicals referred to the November 2018 scheduling meetings (ACMS #25, ACCS #23 and Joint ACMS-ACCS #20).
-
Meeting statementsAdvisory Committee on Complementary Medicines meeting statement for 28 March 2019
-
Meeting statementsCommunique from the second meeting of the TGACC
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsACM 12 meeting statement has been published
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 7 March 2019
-
Scheduling submissionsThe TGA would like to thank respondents who provided submissions in response to the November 2018 public consultation paper
-
Meeting statementsCommunique from the first meeting of the TGACC
-
Meeting statementsACCM meeting statement for 16 November 2018 published
-
Scheduling submissionsPublic submissions on the delegate's interim decisions
-
Scheduling decisions (final)Final decisions and reasons for medicines and chemicals referred to the June 2018 scheduling meetings (ACMS #24 and Joint ACMS-ACCS #19) and delegate-only decisions on agricultural and veterinary chemicals.
-
Meeting statementsThe Advisory Committee on Medicines meeting statement for Meeting 11 is now available
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsAustralian Influenza Vaccine Committee (AIVC) recommendations
-
Meeting statementsAdvisory Committee on Biologicals (ACB), Meeting 11 statement
-
Scheduling decisions (final)Revised final decisions for matters referred to the March 2018 ACMS/ACCS meetings and delegate-only decisions on agricultural chemicals and NCEs.
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 11 October 2018
-
Meeting statementsThe Advisory Committee on Medicines meeting statement is now available
-
Meeting statementsAdvisory Committee on Vaccines meeting statement is now available
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 18 meeting statement
-
Meeting statementsAdvisory Committee on Complementary Medicines Meeting 19 meeting statement
-
Scheduling submissionsPublic submissions on scheduling matters referred to ACMS/ACCS meetings held in March 2018